Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lyons

Showing results (21-30 of 689) with videos related to

Pageof 69
Sort By:
Current Opinion in Genetics & Development|August 1, 1996
Vertebrate heart developmentG E Lyons
JAAPA : Official Journal of the American Academy of Physician Assistants|January 28, 2014
A view from the gurneyStephen E Lyons
American Journal of Obstetrics and Gynecology|April 1, 1989
Late maternal age and postdate pregnancyH Shapiro, E Lyons
Neuroscience and Biobehavioral Reviews|May 29, 2020
Stress and Alzheimer's disease: A senescence link?Carey E Lyons, Alessandro Bartolomucci
Clinical Neuropharmacology|June 15, 2006
Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesiaKelly E Lyons, Rajesh Pahwa
Psychological Assessment|September 15, 2001
Methodological issues in interviewing and using self-report questionnaires with people with mental retardationW M Finlay, E Lyons
The International Journal of Neuroscience|November 1, 2011
Diagnosis and initiation of treatment in Parkinson's diseaseKelly E Lyons, Rajesh Pahwa
Neurologic Clinics|October 27, 2004
Options in the treatment of motor fluctuations and dyskinesias in Parkinson's disease: a brief reviewRajesh Pahwa, Kelly E Lyons
Journal of Neurosurgery|September 24, 2005
Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson diseaseKelly E Lyons, Rajesh Pahwa
Clinical Neuropharmacology|April 15, 2006
Conversion from sustained release carbidopa/levodopa to carbidopa/levodopa/entacapone (stalevo) in Parkinson disease patientsKelly E Lyons, Rajesh Pahwa
Pageof 69

Showing results (21-30 of 689) with videos related to

Sort By:
Pageof 69
Current Opinion in Genetics & Development|August 1, 1996
Vertebrate heart developmentG E Lyons
JAAPA : Official Journal of the American Academy of Physician Assistants|January 28, 2014
A view from the gurneyStephen E Lyons
American Journal of Obstetrics and Gynecology|April 1, 1989
Late maternal age and postdate pregnancyH Shapiro, E Lyons
Neuroscience and Biobehavioral Reviews|May 29, 2020
Stress and Alzheimer's disease: A senescence link?Carey E Lyons, Alessandro Bartolomucci
Clinical Neuropharmacology|June 15, 2006
Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesiaKelly E Lyons, Rajesh Pahwa
Psychological Assessment|September 15, 2001
Methodological issues in interviewing and using self-report questionnaires with people with mental retardationW M Finlay, E Lyons
The International Journal of Neuroscience|November 1, 2011
Diagnosis and initiation of treatment in Parkinson's diseaseKelly E Lyons, Rajesh Pahwa
Neurologic Clinics|October 27, 2004
Options in the treatment of motor fluctuations and dyskinesias in Parkinson's disease: a brief reviewRajesh Pahwa, Kelly E Lyons
Journal of Neurosurgery|September 24, 2005
Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson diseaseKelly E Lyons, Rajesh Pahwa
Clinical Neuropharmacology|April 15, 2006
Conversion from sustained release carbidopa/levodopa to carbidopa/levodopa/entacapone (stalevo) in Parkinson disease patientsKelly E Lyons, Rajesh Pahwa
Pageof 69